Bowel cancer screening research opportunity

Would your practice like to participate in a research project that aims to increase bowel cancer screening rates? Central and Eastern Sydney PHN is working with the Daffodil Centre to support practices in this important work.

Background

Why is this trial important?

Bowel cancer screening can save lives and is freely available to people through the National Bowel Cancer Screening Program (NBCSP). NBCSP participation is currently 40.9 percent nationally and 37.2 percent in the Central Eastern Sydney region.

We know that GP endorsement is key to encouraging people to participate in the program. In this trial, General Practices will be supported in improving bowel cancer screening in their patients through testing evidence-based interventions.

What would I need to do?

General Practices who are eligible for the study will be asked about their bowel screening practices and will agree to share information with the research team over 12 months. You will be randomly allocated to one of two groups and, depending on the group, may also be invited to participate in other activities around bowel cancer screening over a 6-month period.

Being in this study is completely voluntary, and there are no direct costs to the general practice for participation.

When will the study take place?

The study will start in approximately. February 2024. Over the subsequent 12 months, you will be supported by a trial coordinator working with CESPHN to help you through all phases of the study.

Who is running the study?

The project is being led by Associate Professor Eleonora Feletto from the Daffodil Centre, a joint venture between Cancer Council NSW and the University of Sydney and includes a large team of researchers, policy makers and clinicians from across Australia. This study has been approved by the University of Sydney Human Research Ethics Committee (approval number: 2023/496).

For further information, please contact Lauren Walker l.walker@cesphn.com.au